Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Rockville, Maryland

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity’s Internal Medicine research site in Rockville partners with Rockville Internal Medicine Group (RIMG) to conduct clinical trials for a broad range of investigational treatments, including vaccines and medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. Founded in 1952, RIMG began conducting clinical trials with Meridian Clinical Research in 2018, before being acquired by Velocity in 2022. Located just off of I-270, the site is easily accessible to thousands of patients in the Potomac and Rockville areas, including those established with the practice and diverse populations. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Rockville team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Source: Trial-derived.
55Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
16Active Trials
Source: Trial-derived.
33Completed Trials
Source: Trial-derived.
54Unique Conditions
Source: Trial-derived.
32Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. COVID-19 (4)Source: Trial-derived. Respiratory Syncytial Virus (4)Source: Trial-derived. SARS-CoV-2 (4)Source: Trial-derived. Diabetes Mellitus (3)Source: Trial-derived. Gastroparesis (3)Source: Trial-derived. Hypercholesterolemia (3)Source: Trial-derived. Pneumococcal Disease (3)Source: Trial-derived. Chronic Obstructive Pulmonary Disease (2)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (14)Source: Trial-derived. Merck Sharp & Dohme LLC (6)Source: Trial-derived. Janssen Vaccines & Prevention B.V. (4)Source: Trial-derived. Allergan (3)Source: Trial-derived. Pfizer (3)Source: Trial-derived. Apnimed (2)Source: Trial-derived. Biomedical Advanced Research and Development Authority (2)Source: Trial-derived. Phathom Pharmaceuticals, Inc. (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Spirometry

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. ELISA / immunoassay

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. 13C urea breath test
Source: AI-inferred. Electronic clinical outcome assessment (eCOA/e-Diary) platform
Source: AI-inferred. Electronic patient-reported outcome (e-diary) system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Electronic patient-reported outcome diary (ePRO) system
Source: AI-inferred. Fractional exhaled nitric oxide (FeNO) measurement
Source: AI-inferred. Gastric emptying breath test
Source: AI-inferred. Helicobacter pylori antimicrobial susceptibility testing